Registration - Consultant Lobbyist

Return to Intended Outcomes in Lobbying Activity Reports

GlaxoSmithKline Inc. / Darielle Segovia, Consultant Lobbyist

Registration Information

Client name: GlaxoSmithKline Inc.
Lobbyist name: Darielle Segovia, Consultant Lobbyist
Initial registration start date: 2025-10-29
Registration status: Active
Projected end date: No date provided
Registration number: 11057-6270

Associated Lobbying Activity Reports

Total number of Lobbying Activity Reports: 0

Lobbying Activity Reports - last 6 months: 0

Version 1 of 1 (2025-10-29 to present)

Lobbying Information

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will the consultant lobbyist be arranging meetings between a public office holder and the client for the purpose of attempting to influence any of the matters listed:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Advocacy as it relates to Patended Medicines Pricing Review Board and its potential impact on BC's Life Sciences and Research Community	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Advanced Education, COVID-19, Economic Development and Trade, Health
Advocacy related to pharmaceutical and health sciences research	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Advanced Education, COVID-19, Economic Development and Trade, Health, Hospitals, Industry
Discussions regarding pharmaceutical and vaccine procurement, drug and vaccine listings on publicly funded programs and other issues related to access to GSK medicines	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	COVID-19, Economic Development and Trade, Finances and Budgets, Government Procurement, Health, Industry
GSK will conduct activities related to advancement of GSK medicines and vaccines with stakeholders of the healthcare system.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	COVID-19, Economic Development and Trade, Finances and Budgets, Health, Hospitals, Industry
GSK will meet to discuss issues related to access to GSK Medicines and Vaccines, clinical trials and advancement of the life sciences industry	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Advanced Education, COVID-19, Economic Development and Trade, Government Procurement, Health, Hospitals, Industry
Meeting with Government and Healthcare officials to discuss pharmaceutical and health policy, economic development as it relates to clinical trials and other research, scientific information related to GSK's portfolio of medicines and vaccines.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	COVID-19, Economic Development and Trade, Health, Hospitals, Intellectual Property, Science and Technology
Opportunities for collaboration re: Green BC	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Environment, Health, Science and Technology

BC Ministries/Provincial Entities

Finance
Fraser Health Authority
Health
Housing and Municipal Affairs
Innovate BC
Interior Health Authority
Jobs and Economic Growth
Member(s) of the BC Legislative Assembly
Office of the Premier
Parliamentary Secretary for Rural Health
Parliamentary Secretary for Seniors' Services and Long-Term Care
Providence Health Care Society
Provincial Health Services Authority
University of British Columbia
University of Victoria
Vancouver Coastal Health Authority
Vancouver Island Health Authority

Contingency Information

Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the outcome of this lobbying activity.
Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the success in arranging a meeting with public office holders on behalf of the client.

Client Details

Client Contact Information

GlaxoSmithKline Inc.

Address:
100 Milverton Drive
Mississauga, ON L5R 4H1
Canada

Description of Business Activities

GSK is one of the world's leading research-based pharmaceutical and healthcare companies. GSK is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.ca.gsk.com.

Contributors to the Lobbying Activity

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.

Government Funding in the Last 12 Months

No government funding was received within the preceding 12 months based on the submission date requirements for this registration.

Other Entities (working together for the purposes of lobbying) Information

GlaxoSmithKline Inc. is not working together with any other entity for the purpose of lobbying.

Affiliates with a Direct Interest in the Outcome

GlaxoSmithKline plc
- 980 Great West Road
  Brentford, Middlesex TW89GS
  United Kingdom
ID Biomedical Corporation of Quebec
- 2323 boul. du Parc Technologique
  Quebec, QC G1P 4R8
  Canada
Setfirst Limited
- 980 Great West Road
  Brentford, Middlesex TW89GS
  United Kingdom

Other Persons or Organizations with Direct Interests

The activities of GlaxoSmithKline Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.

Lobbyist Details

Darielle Segovia | Has not held any “former public office holder” positions in BC, as defined in the Lobbyists Transparency Act

Business address:
95 St Clair Ave W, Suite 1606
Toronto, ON M4V 1N6
Canada

Relevant Codes of Conduct

The consultant lobbyist does not have in place an undertaking to comply with any relevant codes of conduct.

Political, Sponsorship and Recall Contributions

Consultant has lobbied, or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this client, on or after 2024-09-21:

Yes

Has made a political contribution as defined in the Lobbyists Transparency Act on or after 2024-09-21:	Consultant:	No
	Client:	No
Has made a sponsorship contribution as defined in the Lobbyists Transparency Act on or after 2024-09-21:	Consultant:	No
	Client:	No
Has made a recall contribution as defined in the Lobbyists Transparency Act on or after 2024-09-21:	Consultant:	No
	Client:	No

Gifts or Benefits Provided to Public Officer Holders

No gifts or benefits were provided to public office holders

Individuals Hired or Subcontracted to Lobbying on behalf of the Client

No records

Consultant Lobbyist Firm and Address

Firm: Counsel Public Affairs Inc.

Address:
95 St Clair Ave W, Suite 1606
Toronto, ON M4V 1N6
Canada

Return to Intended Outcomes in Lobbying Activity Reports

GlaxoSmithKline Inc.

Name change history

Name change history
Name	From	To
GlaxoSmithKline Inc.	2025-10-29	current

GlaxoSmithKline Inc.

Senior Officer History
Senior Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Date Modified:: 2025-11-05

Menus

www.lobbyistsregistrar.bc.ca

Registration - Consultant Lobbyist

GlaxoSmithKline Inc. / Darielle Segovia, Consultant Lobbyist

Registration Information

Associated Lobbying Activity Reports

Version 1 of 1 (2025-10-29 to present)

Version 1 of 1 (2025-10-29 to present)

Details Regarding the Identified Subject Matter

BC Ministries/Provincial Entities

Contingency Information

Client Contact Information

Description of Business Activities

Contributors to the Lobbying Activity

Government Funding in the Last 12 Months

Other Entities (working together for the purposes of lobbying) Information

Affiliates with a Direct Interest in the Outcome

Other Persons or Organizations with Direct Interests

Relevant Codes of Conduct

Political, Sponsorship and Recall Contributions

Gifts or Benefits Provided to Public Officer Holders

Individuals Hired or Subcontracted to Lobbying on behalf of the Client

Consultant Lobbyist Firm and Address

Registration - Consultant Lobbyist

GlaxoSmithKline Inc. / Darielle Segovia, Consultant Lobbyist

Version 1 of 1 (2025-10-29 to present)

Details Regarding the Identified Subject Matter

BC Ministries/Provincial Entities

Contingency Information

Client Contact Information

Description of Business Activities

Contributors to the Lobbying Activity

Government Funding in the Last 12 Months

Other Entities (working together for the purposes of lobbying) Information

Affiliates with a Direct Interest in the Outcome

Other Persons or Organizations with Direct Interests

Relevant Codes of Conduct

Political, Sponsorship and Recall Contributions

Gifts or Benefits Provided to Public Officer Holders

Individuals Hired or Subcontracted to Lobbying on behalf of the Client

Consultant Lobbyist Firm and Address

GlaxoSmithKline Inc.

Name change history

GlaxoSmithKline Inc.

Darielle Segovia, Counsel Public Affairs Inc. (Consultant Lobbyist)